Research record
T-VEC / talimogene laherparepvec
An injectable local therapy conversation, not a whole-body targeted therapy or chemotherapy substitute.
What this is
An injectable local therapy conversation, not a whole-body targeted therapy or chemotherapy substitute.
Why it may come up
- injectable/local therapy
- selected melanoma lesions
What not to assume
- Do not describe as a laser or as systemic therapy.
At a glance
T-VEC / talimogene laherparepvec
- Type
- radiation-local
- Mutation result
- any
- Where
- US, EU, Unknown
- Evidence status
- Approved in listed place
- Last checked
- 2026-05-20
What we know
- NCI drug listings include talimogene laherparepvec among drugs approved for melanoma.
What is unclear
- Korea, China, and Japan availability/reimbursement still need dedicated source work.
Questions to ask
- Are there injectable lesions that make local therapy relevant?
- How would this fit with systemic therapy?
- Could local therapy affect trial timing?